Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Camino studies SBP-9330 in first-in-human trial for smoking cessation

Aug. 26, 2021

FDA clears IND application for DCR-AUD

July 30, 2021

Opiant reports topline data from confirmatory PK study of OPNT-003 for opioid overdose

July 7, 2021

New target identified for acetaminophen liver injury

June 14, 2021

NIDA studies TRV-734 in phase II for opioid use disorder

May 31, 2021

FDA clears IND for Lyndra's LYN-014 for weekly treatment of opioid use disorder

May 7, 2021

FDA approves Kloxxado for opioid overdose

May 4, 2021

Cybin targets IND filing for CYB-003 for alcohol use disorder by year-end

April 27, 2021

InterveXion reports phase II data on IXT-m200 in methamphetamine use disorder

April 20, 2021

FDA approves new expanded indication for Anavip

April 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...